---
figid: PMC9683337__fphar-13-1043975-g001
pmcid: PMC9683337
image_filename: fphar-13-1043975-g001.jpg
figure_link: /pmc/articles/PMC9683337/figure/F1/
number: FIGURE 1
figure_title: ''
caption: RANKL induced Osteoclastogenesis (A). RAW264.7 cells were not stimulated
  by RANKL. (B). RANKL-stimulated RAW264.7 cells differentiation into multinucleated
  osteoclasts. (C). Box magnified of osteoclast.
article_title: Receptor activator of nuclear factor-ÎºB ligand-mediated osteoclastogenesis
  signaling pathway and related therapeutic natural compounds.
citation: Zechao Qu, et al. Front Pharmacol. 2022;13:1043975.
year: '2022'

doi: 10.3389/fphar.2022.1043975
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- osteoporosis
- osteoclastogenesis
- RANKL
- signaling pathway
- natural compounds

---
